The juvenile laryngeal papillomatosis is the most frequent benign tumour of the larynx. In Sir Morrel MacKenzie describes papillomas as pharyngo-laryngeal lesions at a child, and the papillomatosis etiology of juvenile laryngeal papillomatosis has been introduced by Chevalier Jakson in The etiological agent is HPV papillomatosis etiology 6 and 11 and the section of papillomatosis etiology respiratory tract the most frequently infected is the squamocolumelar junction.
Juvenile laryngeal papillomatosis is papillomatosis etiology disease more frequent between 3 and 5 years, characterised by multiple relapses and papillomatosis etiology growth at the level of the laryngeal mucosa.
The annual costs of the treatment of this disease are over million USD. The evolution of the disease decreases the quality of the life of the patient and malignancy and death can occur during the disease. Objectives: bringing papillomatosis etiology informations about the etiology, the diagnosis and the treatment of the disease for the specialties that deal with this pathology, especially paediatrics and otolaryngologists.
The evolution of the patients with laryngeal papillomatosis depends on the early diagnosis and the corresponding treatment. Material papillomatosis etiology method: using data from the literature of specialty and the clinical experience in the ENT Clinic in Timisoara we present actualities in the epidemiology, the diagnosis and the treatment in the juvenile laryngeal papillomatosis.
Conclusions: juvenile laryngeal papillomatosis is caused by the HPV types 6 and The treatment follows two objectives: relapses and the reestablishment of the respiratory and phonatory function.